MoneyWorks4Me

A decrease in the sales to Rs. 5775.40 millions was observed for the quarter ended September 2023. The sales stood at Rs. 6248.30 millions during the similar quarter previous year.The Company's Net profit for the September 2023 quarter have declined marginally to Rs. 345.80  millions as against Rs. 365.80 millions reported during the corresponding quarter ended.Operating profit for the quarter ended September 2023 decreased to 661.60 millions as compared to 702.70 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 5775.40 6248.30 -7.57 11691.70 11760.30 -0.58 24979.70 22511.70 10.96
Other Income 7.40 0.90 722.22 13.90 3.30 321.21 22.30 47.80 -53.35
PBIDT 661.60 702.70 -5.85 1387.20 1252.40 10.76 2846.30 3229.50 -11.87
Interest 75.50 82.70 -8.71 153.20 150.60 1.73 325.30 200.60 62.16
PBDT 586.10 620.00 -5.47 1234.00 1101.80 12.00 2521.00 3028.90 -16.77
Depreciation 117.80 119.20 -1.17 235.30 237.50 -0.93 472.90 473.90 -0.21
PBT 468.30 500.80 -6.49 998.70 864.30 15.55 2048.10 2555.00 -19.84
TAX 122.50 135.00 -9.26 257.50 235.00 9.57 520.00 605.00 -14.05
Deferred Tax 12.50 5.00 150.00 20.00 15.00 33.33 -12.50 -50.00 -75.00
PAT 345.80 365.80 -5.47 741.20 629.30 17.78 1528.10 1950.00 -21.64
Equity 919.40 926.00 -0.71 926.00 926.00 0.00 926.00 926.00 0.00
PBIDTM(%) 11.46 11.25 1.86 11.86 10.65 11.41 11.39 14.35 -20.57
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..